Cingulate Inc (CING)
4.65
+0.17
(+3.79%)
USD |
NASDAQ |
Nov 21, 16:00
4.65
0.00 (0.00%)
Pre-Market: 08:50
Cingulate Enterprise Value: 4.897M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 4.897M |
| November 20, 2024 | 4.350M |
| November 19, 2024 | 3.130M |
| November 18, 2024 | 2.873M |
| November 15, 2024 | 3.451M |
| November 14, 2024 | 3.515M |
| November 13, 2024 | 3.869M |
| November 12, 2024 | 3.355M |
| November 11, 2024 | 4.479M |
| November 08, 2024 | 1.106M |
| November 07, 2024 | 1.010M |
| November 06, 2024 | 0.7528M |
| November 05, 2024 | 1.071M |
| November 04, 2024 | 1.619M |
| November 01, 2024 | 1.68M |
| October 31, 2024 | 2.258M |
| October 30, 2024 | 2.928M |
| October 29, 2024 | 3.324M |
| October 28, 2024 | 3.172M |
| October 25, 2024 | 3.263M |
| October 24, 2024 | 4.054M |
| October 23, 2024 | 4.176M |
| October 22, 2024 | 5.759M |
| October 21, 2024 | 4.937M |
| October 18, 2024 | 3.933M |
| Date | Value |
|---|---|
| October 17, 2024 | 3.628M |
| October 16, 2024 | 3.354M |
| October 15, 2024 | 3.506M |
| October 14, 2024 | 3.689M |
| October 11, 2024 | 4.694M |
| October 10, 2024 | 3.506M |
| October 09, 2024 | 3.172M |
| October 08, 2024 | 3.659M |
| October 07, 2024 | 4.785M |
| October 04, 2024 | 4.602M |
| October 03, 2024 | 4.633M |
| October 02, 2024 | 4.602M |
| October 01, 2024 | 4.937M |
| September 30, 2024 | 5.303M |
| September 27, 2024 | 14.93M |
| September 26, 2024 | 15.27M |
| September 25, 2024 | 15.30M |
| September 24, 2024 | 14.87M |
| September 23, 2024 | 10.78M |
| September 20, 2024 | 10.95M |
| September 19, 2024 | 10.82M |
| September 18, 2024 | 10.39M |
| September 17, 2024 | 10.89M |
| September 16, 2024 | 10.41M |
| September 13, 2024 | 11.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.381M
Minimum
Mar 08 2022
48.74M
Maximum
Dec 08 2021
9.042M
Average
8.122M
Median
Enterprise Value Benchmarks
| United Therapeutics Corp | 13.47B |
| Tonix Pharmaceuticals Holding Corp | 17.92M |
| Geovax Labs Inc | 16.88M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.232M |
| Total Expenses (Quarterly) | 3.282M |
| EPS Diluted (Quarterly) | -1.83 |
| Earnings Yield | -6.08K% |